Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial
Nia JulianJune 14, 2021
Facebook0 Twitter Pinterest0 0 Likes
Previous

Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial

Nia JulianJune 15, 2021
Next

Arcellx Announces FDA Clearance of IND Application for ACLX-001, a Controllable Cell Therapy Utilizing the Company’s ARC-SparX Platform, for the Treatment of Multiple Myeloma

Nia JulianApril 7, 2021

© 2020 Solasta Ventures. All Rights Reserved.